34118-92-8CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1.ClIYEWBJUCJHKLHD-UHFFFAOYSA-N34118-92-8DTXSID1045748CHEMBL1256805yellow-beige crystalline powder
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
용도Cardiac depressant (anti-arrhythmic).
일반 설명The GLC assay procedure was developed to study the stability of N-acetylprocainamide hydrochloride (acecainide hydrochloride) in rat feed.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…